Procalcitonin exhibited a sensitivity of 85% and specificity of 91% in differentiating patients with SIRS from those with sepsis, and a sensitivity of 90.3% and a specificity of 90.6% in differentiating patients with severe sepsis / septic shock from those with sepsis.